In Silico Computations of Selective Phytochemicals as Potential Inhibitors Against Major Biological Targets of Diabetes Mellitus

(E-pub Ahead of Print)

Author(s): Ammara Akhtar, Anam Amir, Waqar Hussain, Abdul Ghaffar, Nouman Rasool*.

Journal Name: Current Computer-Aided Drug Design

Become EABM
Become Reviewer


Background: In the past few years, several developments have been made to understand and control the complications and harmful side-effects associated with the disorder diabetes mellitus (DM). Many new steps have been taken in a better understanding of the pathophysiology of the disease. With the advancement in the field of medical sciences, various novel therapies have been developed to efficiently control the pathological effects of diabetes mellitus. Recently, phytochemicals possessing various medicinal properties, have opened up a new vast range of opportunities to design novel therapeutic drugs against diabetes mellitus.

Objective: The present study aims to identify and screen phytochemicals as potent and novel inhibitors against diabetes mellitus.

Methods: Three major biological targets of diabetes mellitus named Cytochrome P450, glycogen synthase kinase and PPARγ are targeted using phytochemicals by performing pharmacological properties prediction, molecular docking and density functional theory studies.

Results: Out of 108 phytochemicals, 20, 12 and 3 phytochemicals showed higher binding affinity values as compared to chemically synthesized drugs against cytochrome P450, glycogen synthase kinase and PPARγ, respectively.

Conclusion: The screened phytochemicals have strong inhibitory potential against diabetes mellitus and in future, these compounds, holding immense potential, can be considered as candidate drugs for treating diabetes mellitus.

Keywords: Diabetes mellitus, Receptors, Phytochemicals, ADMET, Molecular Docking, DFT

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1573409915666190130164923
Price: $95